More than £3bn that could have been used for UK patients will go to big pharma for its branded products – money for care siphoned off for profit
Of Arthur Scargill it was said that he began each day with two newspapers. The miners’ leader read the Morning Star of course, but only after consulting the Financial Times. Why did a class warrior from Yorkshire accord such importance to the house journal of pinstriped Londoners? Before imbibing views, he told a journalist, he wanted “to get the facts”.
In that spirit, let us parse a deal just struck by the governments of Donald Trump and Keir Starmer. You may not have heard much about this agreement on medicine, but it is huge in both financial and political significance – and Downing Street could not be more proud.
A “world-beating deal,” boasts the science minister, Patrick Vallance. It “paves the way for the UK to become a global hub for life sciences,” claims the business secretary, Peter Kyle, with the government press release adding: “Tens of thousands of NHS patients will benefit.”
For months, the Trump administration has warned that semiconductor tariffs are coming soon, leaving the tech industry on pins and needles after a chaotic year of unpredictable tariff regimes collectively cost firms billions.
The semiconductor tariffs are key to Donald Trump’s economic agenda, which is intended to force more manufacturing into the US by making it more expensive to import materials and products. He campaigned on axing the CHIPS Act—which provided subsidies to companies investing in manufacturing chips in the US—complaining that it was a “horrible, horrible thing” to “give hundreds of billions of dollars” away when the US could achieve the same objective by instead taxing companies and “use whatever is left over” of CHIPS funding to “reduce debt.” However, as 2025 winds down, the US president faces pressure on all sides to delay semiconductor tariffs, insiders told Reuters, and it appears that he is considering caving.
According to “two people with direct knowledge of the matter and a third person briefed on the conversations,” US officials have privately told industry and government stakeholders that semiconductor tariffs will likely be delayed.
Login
